Experimental cell research

Regulation of Na(+)-K(+)-ATPase effected high glucose-induced myocardial cell injury through c-Src dependent NADPH oxidase/ROS pathway.

PMID 28551376


Depressed Na(+)/K(+)-ATPase activity has long been reported to be involved in diabetic-related cardiomyocyte death and cardiac dysfunction. However, the nature of directly regulating Na(+)-K(+)-ATPase in diabetic-related myocardial diseases remains unknown. Hyperglycemia is believed as one of major factors responsible for diabetic-related myocardial apoptosis and dysfunction. In this study, whether inhibiting Na(+)-K(+)-ATPase by ouabain or activating Na(+)-K(+)-ATPase by DRm217 has functions on high glucose (HG) -induced myocardial injury was investigated. Here we found that addition of DRm217 or ouabain to HG-treated cells had opposite effects. DRm217 decreased but ouabain increased HG-induced cell injury and apoptosis. This was mediated by changing Na(+)-K(+)-ATPase activity and Na(+)-K(+)-ATPase cell surface expression. The inhibition of Na(+)-K(+)-ATPase endocytosis alleviated HG-induced ROS accumulation. Na(+)-K(+)-ATPase·c-Src dependent NADPH oxidase/ROS pathway was also involved in the effects of ouabain and DRm217 on HG-induced cell injury. These novel results may help us to understand the important role of the Na(+)-K(+)-ATPase in diabetic cardiovascular diseases.